Alexion Pharmaceuticals to acquire Wilson Therapeutics for $855m to enhance rare disease treatment options

In a significant move to expand its rare disease drug portfolio, U.S.-based Alexion Pharmaceuticals has announced an all-cash acquisition of Swedish pharmaceutical company Wilson Therapeutics ... Read More